Person · CIK 1438091
Kira Sheinerman
Director at Niki BioSolutions
Earlier: Xenomics
Sold on Form 4$0
Noticed on Form 144$0
Bought on Form 4$0
Companies2
Holdings now
As reported after the latest Form 3, 4 or 5 at each company.
How these figures work
Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.
| Company | Security | Held | Shares or units | As of |
|---|---|---|---|---|
| Niki BioSolutions NIKI | Common Stock | Directly | 1,515,293 | Jul 20, 2026 · Filing · EDGAR |
| Niki BioSolutions NIKI | Stock Options exercise $8.83, expires Jul 22, 2036, into Common Stock | Directly | 8,000 | Jul 22, 2026 · Filing · EDGAR |
| Xenomics | COMMON STOCK | Directly | 909,090 | Aug 13, 2008 · Filing · EDGAR |
Sold and noticed by quarter
No sales or Form 144 notices with a stated value.
Every transaction, by company
Each Form 3, 4 and 5 transaction in plain words, newest first.
How these figures work
Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.
Xenomics Director · filings 2008 to 2008
All 5 Forms 3, 4, 5 and 144
| Filed | Form | Company | Links |
|---|---|---|---|
| Oct 21, 2026 | Form 4 | Niki BioSolutions NIKI | Filing · EDGAR |
| Oct 21, 2026 | Form 4 | Niki BioSolutions NIKI | Filing · EDGAR |
| Jul 24, 2026 | Form 3 | Niki BioSolutions NIKI | Filing · EDGAR |
| Aug 14, 2008 | Form 4 | Xenomics | Filing · EDGAR |
| Jun 19, 2008 | Form 3 | Xenomics | Filing · EDGAR |
Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.